EFFICIENT IN 52 OUT OF 63 SICK CHILDREN

In the experiment, 63 children and adolescents with cancer were treated with the new method, which had an effect on 52. The method has been approved for people of up to 25 years of age with childhood leukaemia, if nothing else helps.